Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Ultrashort Self-Assembling Peptide Hydrogel for the Treatment of Fungal Infections.

Albadr AA, Coulter SM, Porter SL, Thakur RRS, Laverty G.

Gels. 2018 May 22;4(2). pii: E48. doi: 10.3390/gels4020048.

2.

Development of a teaching model to advance skills in industrial pharmaceutical formulation and regulatory aspects.

Laverty G, Belaid L, Coulter C, Porter S.

Curr Pharm Teach Learn. 2018 Oct;10(10):1419-1428. doi: 10.1016/j.cptl.2018.07.011. Epub 2018 Aug 30.

PMID:
30527372
3.

Self-assembling diphenylalanine peptide nanotubes selectively eradicate bacterial biofilm infection.

Porter SL, Coulter SM, Pentlavalli S, Thompson TP, Laverty G.

Acta Biomater. 2018 Sep 1;77:96-105. doi: 10.1016/j.actbio.2018.07.033. Epub 2018 Jul 19.

PMID:
30031161
4.

Peptide nanomaterials as future antimicrobial technologies.

Laverty G.

Future Microbiol. 2018 Jan;13:5-7. doi: 10.2217/fmb-2017-0208. Epub 2017 Dec 4. No abstract available.

5.

Antibiotic susceptibility of planktonic- and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?

Brady AJ, Laverty G, Gilpin DF, Kearney P, Tunney M.

J Med Microbiol. 2017 Apr;66(4):461-469. doi: 10.1099/jmm.0.000466.

PMID:
28463662
6.

Ultrashort self-assembling Fmoc-peptide gelators for anti-infective biomaterial applications.

McCloskey AP, Draper ER, Gilmore BF, Laverty G.

J Pept Sci. 2017 Feb;23(2):131-140. doi: 10.1002/psc.2951. Epub 2017 Jan 9.

PMID:
28066954
7.

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients.

Rafferty J, Nagaraj H, McCloskey AP, Huwaitat R, Porter S, Albadr A, Laverty G.

Curr Med Chem. 2016;23(37):4231-4259. Review.

PMID:
27633684
8.

Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.

Huwaitat R, McCloskey AP, Gilmore BF, Laverty G.

Future Microbiol. 2016 Jul;11:955-72. doi: 10.2217/fmb-2016-0035. Epub 2016 Jun 30. Review.

PMID:
27357521
9.

Non-thermal Plasma Exposure Rapidly Attenuates Bacterial AHL-Dependent Quorum Sensing and Virulence.

Flynn PB, Busetti A, Wielogorska E, Chevallier OP, Elliott CT, Laverty G, Gorman SP, Graham WG, Gilmore BF.

Sci Rep. 2016 May 31;6:26320. doi: 10.1038/srep26320.

10.

Developing Entrepreneurial Skills in Pharmacy Students.

Laverty G, Hanna LA, Haughey S, Hughes C.

Am J Pharm Educ. 2015 Sep 25;79(7):106. doi: 10.5688/ajpe797106.

11.

Anti-biofilm activity of ultrashort cinnamic acid peptide derivatives against medical device-related pathogens.

Laverty G, McCloskey AP, Gorman SP, Gilmore BF.

J Pept Sci. 2015 Oct;21(10):770-8. doi: 10.1002/psc.2805. Epub 2015 Aug 27.

PMID:
26310860
12.

The use of water-soluble mucoadhesive gels for the intravesical delivery of epirubicin to the bladder for the treatment of non-muscle-invasive bladder cancer.

Chatta D, Cottrell L, Burnett B, Laverty G, McConville C.

J Pharm Pharmacol. 2015 Oct;67(10):1355-62. doi: 10.1111/jphp.12441. Epub 2015 Jun 16.

PMID:
26076758
13.

Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation.

Laverty G, Gorman SP, Gilmore BF.

Pathogens. 2014 Jul 18;3(3):596-632. doi: 10.3390/pathogens3030596. Review.

14.

Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications.

McCloskey AP, Gilmore BF, Laverty G.

Pathogens. 2014 Oct 3;3(4):791-821. doi: 10.3390/pathogens3040791. Review.

15.

Biofilm eradication kinetics of the ultrashort lipopeptide C12 -OOWW-NH2 utilizing a modified MBEC Assay(™).

Laverty G, Gorman SP, Gilmore BF.

Chem Biol Drug Des. 2015 May;85(5):645-52. doi: 10.1111/cbdd.12441. Epub 2014 Oct 23.

PMID:
25264285
16.

Ultrashort cationic naphthalene-derived self-assembled peptides as antimicrobial nanomaterials.

Laverty G, McCloskey AP, Gilmore BF, Jones DS, Zhou J, Xu B.

Biomacromolecules. 2014 Sep 8;15(9):3429-39. doi: 10.1021/bm500981y. Epub 2014 Aug 7.

PMID:
25068387
17.

Using debate to teach pharmacy students about ethical issues.

Hanna LA, Barry J, Donnelly R, Hughes F, Jones D, Laverty G, Parsons C, Ryan C.

Am J Pharm Educ. 2014 Apr 17;78(3):57. doi: 10.5688/ajpe78357.

18.

Biomolecular mechanisms of staphylococcal biofilm formation.

Laverty G, Gorman SP, Gilmore BF.

Future Microbiol. 2013 Apr;8(4):509-24. doi: 10.2217/fmb.13.7. Review.

PMID:
23534362
19.

Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma.

Alkawareek MY, Algwari QT, Laverty G, Gorman SP, Graham WG, O'Connell D, Gilmore BF.

PLoS One. 2012;7(8):e44289. doi: 10.1371/journal.pone.0044289. Epub 2012 Aug 31.

20.

Antimicrobial peptide incorporated poly(2-hydroxyethyl methacrylate) hydrogels for the prevention of Staphylococcus epidermidis-associated biomaterial infections.

Laverty G, Gorman SP, Gilmore BF.

J Biomed Mater Res A. 2012 Jul;100(7):1803-14. doi: 10.1002/jbm.a.34132. Epub 2012 Apr 4.

PMID:
22489028

Supplemental Content

Loading ...
Support Center